Related references
Note: Only part of the references are listed.Melanoma epidemic: Facts and controversies
Corinne Erickson et al.
CLINICS IN DERMATOLOGY (2010)
Incidence and Trends of Cutaneous Malignancies in the Netherlands, 1989-2005
Cynthia Holterhues et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Overdiagnosis in Cancer
H. Gilbert Welch et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
OPINION Explanations for worsening cancer survival
Esther de Vries et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Melanoma epidemic: a midsummer night's dream?
N. J. Levell et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
A Prime minister managed to attract elderly men in a Belgian Euromelanoma campaign
V. del Marmol et al.
EUROPEAN JOURNAL OF CANCER (2009)
Cutaneous melanoma mortality starting to change: A study of trends in Northern Ireland
Anthony Montella et al.
EUROPEAN JOURNAL OF CANCER (2009)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Increasing Burden of Melanoma in the United States
Eleni Linos et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005
Deepak K. Pruthi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Time trends in tumour thickness vary in subgroups: analysis of 6475 patients by age, tumour site and melanoma subtype
Jens Baumert et al.
MELANOMA RESEARCH (2009)
Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990S
Henrike E. Karim-Kos et al.
EUROPEAN JOURNAL OF CANCER (2008)
Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion?
David C. Whiteman et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2008)
Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003
Amy Downing et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site
E. De Vries et al.
ANNALS OF ONCOLOGY (2008)
Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) - A novel strategy for the treatment of melanoma and other malignancies
Steven J. O'Day et al.
CANCER (2007)
Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands
E. de Vries et al.
ANNALS OF ONCOLOGY (2007)
The melanoma epidemic debate: some evidence for a real phenomenon from Tuscany, Italy
Elisabetta Chellini et al.
MELANOMA RESEARCH (2007)
Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003
A. Downing et al.
BRITISH JOURNAL OF CANCER (2006)
Skin biopsy rates and incidence of melanoma: population based ecological study
HG Welch et al.
BRITISH MEDICAL JOURNAL (2005)
Predictions of skin cancer incidence in the Netherlands up to 2015
E de Vries et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Regression models for relative survival
PW Dickman et al.
STATISTICS IN MEDICINE (2004)
Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient?
E de Vries et al.
EUROPEAN JOURNAL OF CANCER (2003)
Incidence of and survival from malignant melanoma in Scotland: an epidemiological study
RM MacKie et al.
LANCET (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)